Insulin Nph Hum/Reg Insulin Hm
Brand name: Humulin 70-30
Rank #185 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$82.3M
Total Cost
177,501
Total Claims
$82.3M
Total Cost
7,961
Prescribers
$464
Cost per Claim
10,513
Beneficiaries
259,382
30-Day Fills
$10K
Avg Cost/Provider
22
Avg Claims/Provider
Share of Medicare Part D Spending
0.03%
of total Medicare Part D spending
$82.3M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $82.3M total
🔎 Data Overview
Average cost of $7,829 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Insulin Nph Hum/Reg Insulin Hm
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Paul Knudson | Endocrinology | Milwaukee, WI | 167 | $242K |
| 2 | Sheila Mercado | Endocrinology | Manati, PR | 651 | $197K |
| 3 | Denise Caro | Endocrinology | Mayaguez, PR | 400 | $173K |
| 4 | Richard Jones | Physician Assistant | Lafayette, IN | 135 | $171K |
| 5 | Pedro Falto Detres | Internal Medicine | Aguadilla, PR | 502 | $156K |
| 6 | Enrique Griego | Family Practice | Mcallen, TX | 126 | $152K |
| 7 | Naomi Collazo Gutierrez | Endocrinology | Manati, PR | 395 | $145K |
| 8 | Carlos Planell Dosal | General Practice | Lares, PR | 332 | $144K |
| 9 | Victor Polanco Sanchez | Internal Medicine | Aibonito, PR | 318 | $143K |
| 10 | Carlos Muniz Molinero | Internal Medicine | Aguada, PR | 398 | $139K |
| 11 | Steven Cowart | Endocrinology | Huntsville, AL | 107 | $128K |
| 12 | Vasdev Lohano | Endocrinology | Washington, IN | 83 | $126K |
| 13 | Jose Montalvo-Figueroa | Endocrinology | Ponce, PR | 302 | $126K |
| 14 | Dalitza Alvarez Valentin | Endocrinology | San Juan, PR | 203 | $120K |
| 15 | Pablo Robles Cortes | General Practice | Lajas, PR | 331 | $113K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 182 | Clopidogrel Bisulfate (Clopidogrel) | $84.7M | 5,428,304 |
| 183 | Famotidine (Famotidine) | $84.3M | 5,257,365 |
| 184 | Mifepristone (Korlym) | $83.3M | 2,397 |
| 185 | Insulin Nph Hum/Reg Insulin Hm (Humulin 70-30) | $82.3M | 177,501 |
| 186 | Montelukast Sodium (Montelukast Sodium) | $81.3M | 5,086,706 |
| 187 | Certolizumab Pegol (Cimzia) | $79.9M | 11,784 |
| 188 | Celecoxib (Celecoxib) | $77.7M | 1,938,505 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology